| 产品描述: | 转谷氨酰胺酶抑制剂;神经保护;Transglutaminase inhibitor; neuroprotective;; |
| 体内研究: |
Cystamine (dihydrochloride) (oral, i.p.; 112, 225 mg/kg) reduces Tgase activity and GGEL levels, lessens the behavioral and neuropathological severity, and extends survival in R6/2 transgenic HD mice. |
| 参考文献: |
1. Mathieu Lesort, et al. Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders. J Biol Chem. 2003 Feb 7;278(6):3825-30. 2. Alpaslan Dedeoglu, et al. Therapeutic effects of cystamine in a murine model of Huntington's disease. J Neurosci. 2002 Oct 15;22(20):8942-50. 3. Thomas M Jeitner, et al. Cystamine and cysteamine as inhibitors of transglutaminase activity in vivo. Biosci Rep. 2018 Sep 5;38(5):BSR20180691. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
4.441 ml |
22.203 ml |
44.407 ml |
| 5 mM |
0.888 ml |
4.441 ml |
8.881 ml |
| 10 mM |
0.444 ml |
2.22 ml |
4.441 ml |
| 50 mM |
0.089 ml |
0.444 ml |
0.888 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |